Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report)’s share price crossed above its 50-day moving average during trading on Friday. The stock has a 50-day moving average of C$4.99 and traded as high as C$5.12. Medexus Pharmaceuticals shares last traded at C$5.12, with a volume of 83,240 shares traded.
Medexus Pharmaceuticals Stock Up 4.1%
The company has a market capitalization of C$160.90 million, a price-to-earnings ratio of -73.14 and a beta of 0.12. The stock has a 50 day simple moving average of C$4.99 and a 200 day simple moving average of C$4.21.
Medexus Pharmaceuticals Company Profile
Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus’s current focus is on the therapeutic areas of hematology and hematology-oncology and rheumatology and allergy.
Read More
- Five stocks we like better than Medexus Pharmaceuticals
- MarketBeat Week in Review – 11/2 – 11/6
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
